Clinical trial
A Phase 1, Open-Label Study to Evaluate Pharmacokinetics and Drug-drug Interactions of ENV-101 in Healthy Participants
NCT07454291 is registered in ClinicalTrials.gov with Endeavor Biomedicines, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1, Open-Label Study to Evaluate Pharmacokinetics and Drug-drug Interactions of ENV-101 in Healthy Participants
- Lead sponsor
- Endeavor Biomedicines, Inc.
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- April 28, 2026
- Completion date
- October 31, 2026
- Enrollment
- 57 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.